Voorwerk, Leonie
Sanders, Joyce http://orcid.org/0000-0002-0551-7813
Keusters, Milou S.
Balduzzi, Sara http://orcid.org/0000-0003-1205-1895
Cornelissen, Sten
Duijst, Maxime
Lips, Esther H. http://orcid.org/0000-0003-3488-4935
Sonke, Gabe S.
Linn, Sabine C. http://orcid.org/0000-0001-5541-0347
Horlings, Hugo M. http://orcid.org/0000-0003-4782-8828
Kok, Marleen http://orcid.org/0000-0001-9043-9815
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-VIDI 09150172010043)
KWF Kankerbestrijding (NKI2015-7542)
Stichting Hendrika Roet Fonds
Article History
Received: 23 June 2022
Accepted: 28 April 2023
First Online: 13 May 2023
Competing interests
: L.V., J.S., M.S.K., S.B., S.C., M.D., and E.H.L. declare no competing financial or non-financial interests. G.S.S. reports the following financial interests: research funding to the institute from Agendia, AstraZeneca, Merck, Novartis, Roche and Seagen and the following non-financial interests: consulting role for Biovica and Seagen, outside the submitted work. S.C.L. reports the following financial interests: research funding to the institute from Roche/Genentech, AstraZeneca, BMS, Tesaro, Merck, Immunomedics, Eurocept Pharmaceuticals, Agendia and Novartis and the following non-financial interests: a consulting role and travel grant from Daiichi Sankyo, outside this work. H.M.H. reports support from Roche Diagnostics, outside the submitted work, and no non-financial interests. M.K. reports the following financial interests: research funding to the institute from BMS, Roche, AstraZeneca/MedImmune and the following non-financial interests: an advisory role for BMS, Roche, MSD and Daiichi Sankyo, outside the submitted work.